We are pleased to announce that the September Decoding Cancer event entitled:
‘New Hope in Multiple Myeloma Treatment’
will take place 6.30pm Thursday 8th September in the O’ Callaghan Alexander Hotel, Dublin.
Myeloma, also known as multiple myeloma, is a cancer of the blood arising from a type of white blood cell which is made in the bone marrow. The uncontrolled growth of these cells can lead to bone pain and fractures, as well as other blood and kidney problems.
Every year in Ireland approximately 250 people are diagnosed with multiple myeloma and 170 succumb to their disease.
In the past a multiple myeloma diagnosis meant that a patient could only expect to survive for three to five years — with chemotherapy the only treatment available.
Today, that landscape has changed considerably with average survival time increasing significantly and additional advances on the horizon with a sophisticated array of new medicines coming into the clinic.
Professor Paul Richardson – a recognised world leader in the development of new treatments for multiple myeloma.
Prof. Richardson is the RJ Corman Professor of Medicine at the Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute.
We hope that you can join us to hear a leading expert speak about cutting edge multiple myeloma research and therapies.
This event is FREE but registration is required. Please Register here on Eventbrite.
For more information please contact email@example.com